TIZANIDINE HYDROCHLORIDE
TIZANIDINE HYDROCHLORIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: TIZANIDINE HYDROCHLORIDE; Generic name: TIZANIDINE HYDROCHLORIDE; Manufacturer: TIZANIDINE HYDROCHLORIDE.
| Brand name | TIZANIDINE HYDROCHLORIDE |
|---|---|
| Generic name | TIZANIDINE HYDROCHLORIDE |
| Manufacturer | TIZANIDINE HYDROCHLORIDE |
| Used for | INDICATIONS & USAGE SECTION Tizanidine tablet is a short-acting drug for the management of spasticity. Because of the short duration of effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important (see DOSAGE AND ADMINISTRATION). |
| Dosage | DOSAGE & ADMINISTRATION SECTION A single dose of 8 mg of tizanidine reduces muscle tone in patients with spasticity for a period of several hours. The effect peaks at approximately 1 to 2 hours and dissipates between 3 to 6 hours. Effects are dose-related. Although single doses of less than 8 mg have not been demonstrated to be effective in controlled clinical studies, the dose-related nature of tizanidine's common adverse events make it prudent to begin treatment with single oral doses of 4 mg. |
| Warnings | WARNINGS SECTION LIMITED DATA BASE FOR CHRONIC USE OF SINGLE DOSES ABOVE 8 MG AND MULTIPLE DOSES ABOVE 24 MG PER DAY Clinical experience with long-term use of tizanidine at doses of 8 to 16 mg single doses or total daily doses of 24 to 36 mg (see Dosage and Administration) is limited. In safety studies, approximately 75 patients have been exposed to individual doses of 12 mg or more for at least one year or more and approximately 80 patients have been exposed to total daily doses of 30 to 36 mg/ |
| Active ingredient(s) | TIZANIDINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=047c67cd-7a63-49c9-b100-71651d3537ba |